FIGURE

Figure 4

ID

ZDB-FIG-191230-1500

Publication

Collodet et al., 2019 - AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR

Other Figures

All Figure Page

Back to All Figure Page

Figure 4

Identification of pathways and genes modulated by AMPK. A, B) Gene enrichment analysis of the 991-responsive signature in MEFs (A) and mouse primary hepatocytes (B). DAVID was used to explore the gene ontology terms associated to the AMPK-regulated genes. The bars represent the negative log₁₀ (P value) of enriched terms, indicating the significance of association between the gene list and an indicated ontology term. C, D) Relative mRNA levels of the indicated genes are displayed following qPCR analysis in MEFs (C) and primary hepatocytes (D). AMPKα1α2^+/+ or AMPKα1α2^−/− MEFs were stimulated with 10 µM 991 or 2 mM AICAR for 4 h, and AMPKα1α2^+/+ or AMPKα1α2^−/− hepatocytes were treated with 3 µM 991 or 300 µM AICAR for 4 h. The color corresponds to the 2 treatment conditions and 2 cellular models, as indicated in the figure. Values are represented as log₂ fold-change of the mean ± sd (n = 9). The gray shaded area indicates the log₂ fold-change threshold of ±0.37. For the analysis, a 2-way ANOVA with interaction was fit to log-transformed data. *P < 0.05, **P < 0.01, ***P < 0.001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ FASEB J.